![](https://endpts.com/wp-content/uploads/2021/07/Ryan-Watts-1-scaled.jpg)
Ryan Watts, Denali CEO
Denali slips as a snapshot of early data raises some troubling questions on its pioneering blood-brain barrier neuro work
Denali Therapeutics had drummed up considerable hype for their blood-brain barrier technology since launching over six years ago, hype that’s only intensified in the last …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.